Literature DB >> 3312018

Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan.

H Gaylord1, P J Brennan, D B Young, T M Buchanan.   

Abstract

Each of more than 30 monoclonal antibodies that had been raised against Mycobacterium leprae and previously classified as reactive with carbohydrate was shown to be directed against lipoarabinomannan, a prominent, highly pervasive, myo-inositol-phosphate-containing, cross-reactive antigen within the leprosy bacillus. Some of the antibodies preferentially bound to the lipopolysaccharide of M. leprae rather than to that of Mycobacterium tuberculosis, suggesting the presence of distinguishing structural features. The presence of alkali-labile inositol 1-phosphate in the lipopolysaccharide from M. tuberculosis and its apparent absence from the M. leprae product may account for the difference.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312018      PMCID: PMC259992          DOI: 10.1128/iai.55.11.2860-2863.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Chemical and biological properties of the hemagglutination antigen, a lipopolysaccharide, of Mycobacterium tuberculosis, var. hominis.

Authors:  T TSUMITA; R MATSUMOTO; D MIZUNO
Journal:  Jpn J Med Sci Biol       Date:  1960-06

Review 2.  Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties.

Authors:  T M Daniel; B W Janicki
Journal:  Microbiol Rev       Date:  1978-03

3.  Definition of species specific and cross-reactive antigenic determinants of Mycobacterium leprae using monoclonal antibodies.

Authors:  J Ivanyi; S Sinha; R Aston; D Cussell; M Keen; U Sengupta
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

4.  SDS-PAGE analysis of M. leprae protein antigens reacting with antibodies from sera from lepromatous patients and infected armadillos.

Authors:  A K Chakrabarty; M A Maire; P H Lambert
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

5.  Studies on the chemical structure of serologically active arabinomannan from mycobacteria.

Authors:  M Oashi
Journal:  Jpn J Exp Med       Date:  1970-02

6.  Immunochemical characterization of Mycobacterium leprae antigens by the SDS-polyacrylamide gel electrophoresis immunoperoxidase technique (SGIP) using patients' sera.

Authors:  P R Klatser; M M van Rens; T A Eggelte
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

7.  Structural and immunochemical characterization of the acidic arabinomannan of Mycobacterium smegmatis.

Authors:  P L Weber; G R Gray
Journal:  Carbohydr Res       Date:  1979-09       Impact factor: 2.104

8.  Production and characterization of a murine monoclonal antibody recognizing a shared mycobacterial polysaccharide.

Authors:  R A Miller; T M Buchanan
Journal:  Int J Lepr Other Mycobact Dis       Date:  1984-12

9.  Production and partial characterization of monoclonal antibodies to Mycobacterium leprae.

Authors:  T P Gillis; T M Buchanan
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

10.  Structural and immunochemical studies on D-arabino-D-mannans and D-mannans of Mycobacterium tuberculosis and other Mycobacterium species.

Authors:  A Misaki; I Azuma; Y Yamamura
Journal:  J Biochem       Date:  1977-12       Impact factor: 3.387

View more
  28 in total

1.  Results of the third immunology of leprosy/immunology of tuberculosis antimycobacterial monoclonal antibody workshop.

Authors:  S Khanolkar-Young; A H Kolk; A B Andersen; J Bennedsen; P J Brennan; B Rivoire; S Kuijper; K P McAdam; C Abe; H V Batra
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

2.  Comparative Structural Study of Terminal Ends of Lipoarabinomannan from Mice Infected Lung Tissues and Urine of a Tuberculosis Positive Patient.

Authors:  Prithwiraj De; Libin Shi; Claudia Boot; Diane Ordway; Michael McNeil; Delphi Chatterjee
Journal:  ACS Infect Dis       Date:  2019-12-12       Impact factor: 5.084

Review 3.  Antigens of the Mycobacterium avium, Mycobacterium intracellulare complex.

Authors:  S L Morris
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

4.  Specificity of IgG subclass antibodies in different clinical manifestations of leprosy.

Authors:  S Dhandayuthapani; S Izumi; D Anandan; V N Bhatia
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

5.  Enzyme-linked immunosorbent assay for distinguishing serological responses of lepromatous and tuberculoid leprosies to the 29/33-kilodalton doublet and 64-kilodalton antigens of Mycobacterium tuberculosis.

Authors:  P K Das; A Rambukkana; J G Baas; D G Groothuis; M Halperin
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

Review 6.  Immunological study of the defined constituents of mycobacteria.

Authors:  J Ivanyi; K Sharp; P Jackett; G Bothamley
Journal:  Springer Semin Immunopathol       Date:  1988

7.  Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions.

Authors:  M Harboe; P Garred; M S Borgen; G L Stahl; A Roos; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

8.  Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages.

Authors:  T I Roach; C H Barton; D Chatterjee; F Y Liew; J M Blackwell
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

9.  Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components.

Authors:  Y Zhang; M Doerfler; T C Lee; B Guillemin; W N Rom
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  The use of antigen-bearing nitrocellulose particles derived from Western blots to study proliferative responses to 27 antigenic fractions from Mycobacterium leprae in patients and controls.

Authors:  E Filley; C Abou-Zeid; M Waters; G Rook
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.